Jpmorgan Chase & Co »

Iovance Biotherapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $23M 2.8M 8.13
2023-09-30 $13M 2.7M 4.55
2023-06-30 $19M 2.6M 7.04
2023-03-31 $11M 1.9M 5.71
2022-12-31 $15M 2.3M 6.39
2022-06-30 $23M 2.0M 11.18
2022-03-31 $31M 1.9M 16.65
2021-12-31 $38M 2.0M 18.82
2021-03-31 $43M 1.3M 31.66
2020-12-31 $44M 943k 46.40
2020-09-30 $23M 704k 32.30
2020-06-30 $17M 626k 27.45
2020-03-31 $17M 558k 29.94
2019-12-31 $15M 536k 27.68
2019-09-30 $8.6M 474k 18.20
2019-06-30 $11M 464k 22.61
2019-03-31 $4.2M 445k 9.51
2018-12-31 $4.0M 449k 8.84
2018-09-30 $4.8M 428k 11.25
2018-06-30 $5.6M 436k 12.80
2018-03-31 $8.6M 510k 16.90
2017-12-31 $10M 1.3M 7.98
2017-06-30 $8.0M 1.1M 7.36